Darunavir and Impurities
Ref: 4Z-D-3716
10mg | To inquire | ||
25mg | To inquire | ||
50mg | To inquire | ||
100mg | To inquire |
Estimated delivery in United States, on Wednesday 19 Feb 2025
1-epi-Darunavir
Controlled ProductCAS:1546918-95-9
Applications Stereoisomer to Darunavir (D193500), a second generation HIV-1-protease inhibitor; structurally similar to amprenavir. Antiviral. …
Formula:
C27H37N3O7S
Color and Shape:
White To Off-White
Molecular weight:
547.66
Ref: TR-D193505
1mg | 531.00 € |
Estimated delivery in United States, on Monday 24 Feb 2025
Darunavir-d9
Controlled ProductCAS:1133378-37-6
Applications Second generation HIV-1-protease inhibitor; structurally similar to amprenavir. Antiviral. It is a COVID19-related research …
Formula:
C27H9H28N3O7S
Color and Shape:
Off-White To Light Beige
Molecular weight:
556.72
Ref: TR-D193502
1mg | 465.00 € | ||
10mg | 3,260.00 € |
Estimated delivery in United States, on Monday 24 Feb 2025
Darunavir
CAS:206361-99-1
Applications Second generation HIV-1-protease inhibitor; structurally similar to amprenavir. Antiviral. It is a COVID19-related research …
Formula:
C27H37N3O7S
Color and Shape:
Beige
Molecular weight:
547.66
Ref: TR-D193500
5mg | 125.00 € | ||
10mg | 155.00 € | ||
50mg | 567.00 € |
Estimated delivery in United States, on Monday 24 Feb 2025
Darunavir N-β-D-Glucuronide Sodium Salt (90%)
Controlled ProductCAS:1159613-25-8
Applications Darunavir N-β-D-Glucuronide Sodium Salt (90%) is a salt analogue of Darunavir N-β-D-Glucuronide (D193510), which …
Formula:
C33H44N3NaO13S
Purity:
90%
Color and Shape:
Neat
Molecular weight:
745.77
Ref: TR-D193513
1mg | 624.00 € | ||
10mg | 4,620.00 € |
Estimated delivery in United States, on Tuesday 25 Mar 2025
2-epi-Darunavir
CAS:850141-19-4
Applications 2-epi-Darunavir is a stereoisomer to Darunavir (D193500), a second generation HIV-1-protease inhibitor; structurally similar …
Formula:
C27H37N3O7S
Color and Shape:
Neat
Molecular weight:
547.66
Ref: TR-D193530
10mg | 1,035.00 € | ||
25mg | 1,886.00 € |
Estimated delivery in United States, on Tuesday 25 Mar 2025